Allan Frank Fischer Petersen

Director/Miembro de la Junta en Biogen (Denmark) A/S .

Health Technology

Perfil

Allan Frank Fischer Petersen is currently a Director at Biogen (Denmark).
A since 2012.
He previously worked as the Chief Executive Officer at FUJIFILM Diosynth Biotechnologies Holdings Denmark ApS.

Cargos activos de Allan Frank Fischer Petersen

Empresas	Cargo	Inicio
Biogen (Denmark) A/S Biogen (Denmark) A/S BiotechnologyHealth Technology Biogen (Denmark) A/S manufactures therapies and pharmaceuticals. The company is headquartered in Glostrup, Denmark.	Director/Miembro de la Junta	10/04/2012

Todos los cargos activos de Allan Frank Fischer Petersen

Antiguos cargos conocidos de Allan Frank Fischer Petersen.

Empresas	Cargo	Fin
Biogen (Denmark) New Manufacturing ApS Biogen (Denmark) New Manufacturing ApS BiotechnologyHealth Technology Biogen (Denmark) New Manufacturing ApS engages in neuroscience. The firm offers therapies for multiple sclerosis, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, as well as less common diseases such as spinal muscle atrophy, and progressive supranuclear palsy. The company was founded on July 1, 2008 and is headquartered in Hillerod, Denmark.	Director Ejecutivo	-

Ver el detalle de la experiencia de Allan Frank Fischer Petersen.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Allan Frank Fischer Petersen.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Biogen (Denmark) A/S Biogen (Denmark) A/S BiotechnologyHealth Technology Biogen (Denmark) A/S manufactures therapies and pharmaceuticals. The company is headquartered in Glostrup, Denmark.	Health Technology
Biogen (Denmark) New Manufacturing ApS Biogen (Denmark) New Manufacturing ApS BiotechnologyHealth Technology Biogen (Denmark) New Manufacturing ApS engages in neuroscience. The firm offers therapies for multiple sclerosis, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, as well as less common diseases such as spinal muscle atrophy, and progressive supranuclear palsy. The company was founded on July 1, 2008 and is headquartered in Hillerod, Denmark.	Health Technology